#Molecular Diagnostics

Co-Diagnostics Moves Q3 2026 Earnings Release to November 10

Co-Diagnostics shifts its Q3 2026 earnings release and investor webcast to November 10, 2026, two days earlier than the company's original announcement.

Co-Diagnostics Schedules Third Quarter 2026 Financial Results Release

Co-Diagnostics, Inc. (CODX) announced the date for its third quarter 2026 earnings release and investor webcast, providing a routine update on the…

BillionToOne SVP Ten Bosch Sells 1,416 Shares in Routine Trade

BillionToOne SVP John Roderick Ten Bosch offloaded 1,416 shares via a Rule 10b5-1 plan, maintaining a significant $2.4 million stake in the…

Natera CEO Steven Chapman Sells 1,698 Shares in Preplanned Transaction

Natera CEO Steven Chapman offloaded 1,698 shares via a pre-established 10b5-1 trading plan, a move that market observers view as routine given…